Human neurotrophin receptor p75NTR defines differentiation-oriented skeletal muscle precursor cells: Implications for muscle regeneration

Journal of Neuropathology and Experimental Neurology

Volumn 70, Issue 2, 2011, Pages 133-142

  Colombo, Emanuela ^a   Romaggi, Stefania ^a   Medico, Enzo ^b   Menon, Ramesh ^a   Mora, Marina ^a   Falcone, Chiara ^a   Lochmüller, Hanns ^c   Confalonieri, Paolo ^a   Mantegazza, Renato ^a   Morandi, Lucia ^a   Farina, Cinthia ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Dystrophin; Myogenesis; Neurotrophins; p75NTR neurotrophin receptor; Regeneration; Satellite cell; Skeletal muscle

Indexed keywords

BIOLOGICAL MARKER; DYSTROPHIN; MESSENGER RNA; NEUROTROPHIN RECEPTOR P75; PROTEIN; RECEPTOR; TRANSCRIPTOME;

ADULT; ARTICLE; BECKER MUSCULAR DYSTROPHY; CELL DIFFERENTIATION; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOMYOSITIS; GENE SILENCING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INCLUSION BODY MYOSITIS; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; MYOBLAST; POLYMYOSITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BLOCKING; SKELETAL MUSCLE; SKELETAL MUSCLE SATELLITE CELL; STEM CELL; TRANSCRIPTOMICS;

ANTIBODIES, BLOCKING; APOPTOSIS REGULATORY PROTEINS; BIOPSY; CELL DIFFERENTIATION; CELLS, CULTURED; DNA, COMPLEMENTARY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; MUSCLE FIBERS, SKELETAL; MUSCULAR DISEASES; MYOBLASTS; REGENERATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SATELLITE CELLS, SKELETAL MUSCLE; STEM CELLS;

EID: 79251595304     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3182084391     Document Type: Article

References (37)

1. Schubert W, Zimmermann K, Cramer M, et al. Lymphocyte antigen Leu-19 as a molecular marker of regeneration in human skeletal muscle. Proc Natl Acad Sci USA 1989;86:307-11
2. Seale P, Sabourin LA, Girgis-Gabardo A, et al. Pax7 is required for the specification of myogenic satellite cells. Cell 2000;102:777-86
3. Tajbakhsh S, Rocancourt D, Buckingham M. Muscle progenitor cells failing to respond to positional cues adopt non-myogenic fates in myf-5 null mice. Nature 1996;384:266-70
4. Beauchamp JR, Heslop L, Yu DS, et al. Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells. J Cell Biol 2000;151:1221-34
5. Le Grand F, Rudnicki MA. Skeletal muscle satellite cells and adult myogenesis. Curr Opin Cell Biol 2007;19:628-33
6. Bryson-Richardson RJ, Currie PD. The genetics of vertebrate myo-genesis. Nat Rev Genet 2008;9:632-46
7. Dechant G, Barde YA. The neurotrophin receptor p75(NTR): Novel functions and implications for diseases of the nervous system. Nat Neurosci 2002;5:1131-36
8. Huang EJ, Reichardt LF. Trk receptors: Roles in neuronal signal trans-duction. Annu Rev Biochem 2003;72:609-42
9. Horner PJ, Gage FH. Regenerating the damaged central nervous system. Nature 2000;407:963-70
10. Yano H, Chao MV. Mechanisms of neurotrophin receptor vesicular transport. J Neurobiol 2004;58:244-57
11. Wang XH, Poo MM. Potentiation of developing synapses by post-synaptic release of neurotrophin-4. Neuron 1997;19:825-35
12. Xie K, Wang T, Olafsson P, et al. Activity-dependent expression of NT-3 in muscle cells in culture: Implications in the development of neuro-muscular junctions. J Neurosci 1997;17:2947-58
13. Gonzalez M, Ruggiero FP, Chang Q, et al. Disruption of Trkb-mediated signaling induces disassembly of postsynaptic receptor clusters at neuromuscular junctions. Neuron 1999;24:567-83
14. Lavasani M, Lu A, Peng H, et al. Nerve growth factor improves the muscle regeneration capacity of muscle stem cells in dystrophic muscle. Hum Gene Ther 2006;17:180-92
15. Seidl K, Erck C, Buchberger A. Evidence for the participation of nerve growth factor and its low-affinity receptor (p75NTR) in the regulation of the myogenic program. J Cell Physiol 1998;176:10-21
16. Rende M, Brizi E, Conner J, et al. Nerve growth factor (NGF) influences differentiation and proliferation of myogenic cells in vitro via TrKA. Int J Dev Neurosci 2000;18:869-85
17. Mousavi K, Jasmin BJ. BDNF is expressed in skeletal muscle satellite cells and inhibits myogenic differentiation. J Neurosci 2006;26:5739-49
18. Deponti D, Buono R, Catanzaro G, et al. The low-affinity receptor for neurotrophins p75NTR plays a key role for satellite cell function in muscle repair acting via RhoA. Mol Biol Cell 2009;20:3620-27
19. Berzi A, Ayata CK, Cavalcante P, et al. BDNF and its receptors in human myasthenic thymus: Implications for cell fate in thymic pathology. J Neuroimmunol 2008;197:128-39
20. Dennis G Jr, Sherman BT, Hosack DA, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003;4:P3
21. Van Iersel MP, Kelder T, Pico AR, et al. Presenting and exploring biological pathways with PathVisio. BMC Bioinformatics 2008;9:399
22. Davie JK, Cho JH, Meadows E, et al. Target gene selectivity of the myo-genic basic helix-loop-helix transcription factor myogenin in embryonic muscle. Dev Biol 2007;311:650-64
23. Chiu YH, Hornsey MA, Klinge L, et al. Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy. Hum Mol Genet 2009;18:1976-89
24. Sherwood RI, Christensen JL, Conboy IM, et al. Isolation of adult mouse myogenic progenitors: Functional heterogeneity of cells within and engrafting skeletal muscle. Cell 2004;119:543-54
25. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003;362:971-82
26. Needham M, Mastaglia FL. Inclusion body myositis: Current pathoge-netic concepts and diagnostic and therapeutic approaches. Lancet Neurol 2007;6:620-31
27. Lim LE, Rando TA. Technology insight: Therapy for Duchenne muscular dystrophyVAn opportunity for personalized medicine? Nat Clin Pract Neurol 2008;4:149-58
28. Baron P, Scarpini E, Meola G, et al. Expression of the low-affinity NGF receptor during human muscle development, regeneration, and in tissue culture. Muscle Nerve 1994;17:276-84
29. Darabi R, Santos FN, Perlingeiro RC. The therapeutic potential of embryonic and adult stem cells for skeletal muscle regeneration. Stem Cell Rev 2008;4:217-25
30. Ervasti JM. Dystrophin, its interactions with other proteins, and implications for muscular dystrophy. Biochim Biophys Acta 2007;1772: 108-17
31. Acharyya S, Butchbach ME, Sahenk Z, et al. Dystrophin glycoprotein complex dysfunction: A regulatory link between muscular dystrophy and cancer cachexia. Cancer Cell 2005;8:421-32
32. Ruberti F, Capsoni S, Comparini A, et al. Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen, and skeletal muscle dystrophy. J Neurosci 2000;20:2589-601
33. Murphy RA, Singer RH, Saide JD, et al. Synthesis and secretion of a high molecular weight form of nerve growth factor by skeletal muscle cells in culture. Proc Natl Acad Sci USA 1977;74:4496-500
34. Liem RS, Brouwer N, Copray JC. Ultrastructural localisation of intramuscular expression of BDNF mRNA by silver-gold intensified non-radioactive in situ hybridisation. Histochem Cell Biol 2001;116: 545-51
35. Kust BM, Copray JC, Brouwer N, et al. Elevated levels of neurotrophins in human biceps brachii tissue of amyotrophic lateral sclerosis. Exp Neurol 2002;177:419-27
36. Toti P, Villanova M, Vatti R, et al. Nerve growth factor expression in human dystrophic muscles. Muscle Nerve 2003;27:370-73
37. Clow C, Jasmin BJ. Brain-derived neurotrophic factor regulates satellite cell differentiation and skeletal muscle regeneration. Mol Biol Cell 2010;21: 2182-90